Apoptosis and proliferation related molecules (Bcl-2, Bax, p53, PCNA) in papillary microcarcinoma versus papillary carcinoma of the thyroid
Abstract
To gain a better insight into the differences in biological behaviour between papillary microcarcinoma (PMC) and clinically evident papillary thyroid carcinoma (PTC). Immunohistochemical analysis of apoptosis related molecules (Bcl-2, Bax, p53) and proliferation related marker (PCNA) in 39 archival cases of PMC and 46 cases of PTC. Bcl-2 and Bax were expressed in most PMCs and PTCs. The average Bcl-2 staining score did not differ significantly between PMCs and PTCs (p > 0.05), but the average Bax score was significantly lower in PMCs (p < 0.05). The Bcl-2/Bax ratio was significantly higher in PMCs than in PTCs (p < 0.05). The expression of p53 was similar in PMCs and PTCs, without a correlation with clinical data, but was associated with high Bax expression (p < 0.05) in these cases in both groups. Non-malignant tissue expressed only Bcl-2, but not p53 or Bax. PCNA expression was significantly lower (p < 0.05) in PMC than in PTC and positively correlated with tumour size (p < 0.05). The higher Bcl-2/Bax ratio and lower proliferative activity in PMC suggest differences from PTC in the balance between apoptosis and proliferation. However, the presence of p53 and Bax in PMC indicates malignant potential, and thus PMC should be treated with caution.Keywords
This publication has 30 references indexed in Scilit:
- Papillary thyroid microcarcinoma (PTMC): Prognostic factors, management and outcome in 403 patientsEuropean Journal of Surgical Oncology, 2006
- FLIPping the Balance between Apoptosis and Proliferation in Thyroid CancerClinical Cancer Research, 2006
- Papillary Microcarcinomas of the Thyroid with Preoperatively Detectable Lymph Node Metastasis Show Significantly Higher Aggressive Characteristics on Immunohistochemical ExaminationOncology, 2005
- Immunohistochemical Expression of Bcl-2, Ki-67, and p21 in Patients with Papillary Thyroid CancerTumor Biology, 2005
- Apoptosis in thyroid neoplasms: relationship with p53 and bcl‐2 expressionHistopathology, 1998
- Prognostic factors for thyroid carcinomaCancer, 1997
- Thyroid carcinoma: clinical, pathologic correlationsCritical Reviews in Oncology/Hematology, 1995
- Bcl-2 and the regulation of programmed cell deathJournal of Cell Biology, 1994
- The cell cycle and cell deathCurrent Biology, 1993
- The p53 tumour suppressor geneNature, 1991